type1diabetes
Conditions
Brief summary
Type 1 diabetes (T1D) is one of the most common chronic illnesses of childhood. The involved treatment regimen, including daily insulin administration/pump management, frequent blood glucose checks, and careful track-ing of food intake, places a high-stress burden on patients and their families. Adolescence is a particularly risky time for T1D management given a marked decline in treatment adherence and glycemic control. Over 80% of adolescents with T1D have poor glycemic control (A1c \>7.5%), and one significant risk factor is the increase in negative affectivity, including depression and anxiety symptoms, that distinguish adolescents with T1D. Elevated depression and anxiety symptoms affect 40% of teens with T1D. Preliminary data support the notion that negative affectivity contributes to diminished treatment adherence and worsening of glycemic control, partially through the effects of negative affectivity on stress-related behavior such as maladaptive eating behavior (e.g., dietary restriction, uncontrolled eating patterns, and insulin omission for weight control). There is no gold-standard approach to address the poor glycemic control seen in adolescents with T1D. The creation of novel, targeted interventions, tailored for the developmental needs of adolescents with T1D and the particular burdens of coping with their chronic illness, are needed. Mindfulness-based interventions delivered to adolescents without T1D, including the team's preliminary work in teens with depression and weight-related disorders, have shown promise in treating negative affectivity, maladaptive eating behavior, and health outcomes. A mindfulness-based approach may be well-suited for adolescents with T1D, but given that the mechanisms of association among negative affectivity, stress-related behavior, and self-care are unique to individuals with T1D, interventions must be specifically tailored for this population. The goal of this study is to, therefore, adapt an existing 6-session mindfulness-based intervention, Learning to BREATHE, for use with adolescents with T1D (BREATHE-T1D). The first specific aim of the study is to adapt BREATHE for adolescents with T1D and to adapt a relevant and credible health education comparison curriculum (HealthEd-T1D). The second aim is to carry out a 2-way pilot randomized controlled trial to evaluate the feasibility and acceptability of BREATHE-T1D and HealthEd-T1D. The result of the current study will be a feasible and acceptable mindfulness intervention and comparison curriculum that can be evaluated in an efficacy trial. The multidisciplinary study team contributes complementary areas of expertise in adolescents with T1D, behavioral intervention development, negative affectivity and maladaptive eating behavior, adolescent mindfulness-based intervention, qualitative data analysis, and delivery of behavioral health interventions via telehealth. The study's innovative approach will enable the investigators to establish a feasible/acceptable intervention tailored for adolescents with T1D, leading to a future proposal for a full-scale efficacy trial.
Interventions
BREATHE-T1D is a mindfulness based intervention adapted from Learning to BREATHE specifically for teens with type 1 diabetes.
Sponsors
Study design
Eligibility
Inclusion criteria
* age 12-17y * T1D, with at least 1-year duration of illness * negative affectivity, defined as clinically elevated scores (T-score \>55 indicating at least mild depression/anxiety symptoms on either the PROMIS short form-depression and/or anxiety scales) * A1c \>7.5% * English-speaking
Exclusion criteria
* no cognitive or developmental delays which would interfere with their ability to participate in the study * are able and willing to complete questionnaires and intervention via the internet * do not have severe depression or active or recent (within the past two months) suicidal ideation * have no other serious medical conditions (e.g., cystic fibrosis, cancer).
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Percentage of Enrolled of Eligible Participants Screened | During screening (10 months total) | The percentage is calculated first by identifying the number of enrolled participants divided by eligible participants. 42 total patients were eligible once screened across the 10 month enrollment period. 42 total then enrolled in the study. |
| Number of Weeks to Enroll Participants to Form One Cohort | During screening (10 months) | Number of weeks to enroll 10 participants to be randomized 5 per group |
| Percentage of Participants With Data Collected | Baseline, Immediate post-intervention (2-3 months post baseline), 3 month follow up (5-6 months post baseline) | Number of participants with data at each time point. |
| Percentage of Attended Sessions | Immediate post-intervention follow-up (2-3 months post baseline) | Number of intervention sessions (calculated by multiplying number of expected sessions by number of participants for total possible sessions held) attended divided by total number of intervention sessions expected per group. |
| Satisfaction With Intervention Program | Immediate post-intervention follow-up (2-3 months post-baseline) | Satisfaction report by participants |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| UPPS-P Negative Urgency Subscale | Baseline, Immediate post-intervention (2-3 months post baseline), 3 month follow up (5-6 months post baseline) | Teen report on the UPPS-P Negative Urgency subscale with higher scores indicating more likelihood to act impulsively when experiencing a negative mood. Scores are calculated with an average which can range from 1(minimum) to 4 (maximum). |
| Self-Care Inventory | Baseline, Immediate post-intervention (2-3 months post baseline), 3 month follow up (5-6 months post baseline) | Teen report on the Self-Care Inventory, a measure of diabetes management with higher scores indicating better self-care for diabetes. Average scores range from 1 (minimum) to 5 (maximum). |
| Mindful Attention Awareness Scale | Baseline, Immediate post-intervention (2-3 months post baseline), 3 month follow up (5-6 months post baseline) | Assessed via teen report. Scores are calculated as an average score of all items with a range of 1 (minimum) to 6 (maximum) with higher scores indicating more mindful attention in daily life. |
| Glycemic Control | Baseline, immediate post intervention follow up (2-3 months post baseline), 3 month follow up (5-6 months post baseline) | HbA1c is a measure of an average blood glucose level over the past 3 months and will be abstracted from the medical record as it is assessed at each regular diabetes clinic visit. HbA1c typically ranges from 4% to \>14%. |
| Interventionist Adherence to Session Manuals | Week 6 of intervention | Supervisors listened to recordings of sessions for both programs and completed checklists assessing for the number of expected intervention components included in the sessions. Therefore, values reflect the percentage of expected intervention components included across all program sessions calculated at the end of the intervention period (week 6) for each group cohort. |
| Problem Areas in Diabetes - Teen | Baseline, immediate post intervention (2-3 months post baseline), 3 month follow up (5-6 months post baseline) | The Problem Areas in Diabetes-Teen (PAID-T) is a 14-item measure of diabetes distress in adolescents with type 1 diabetes. Adolescents are asked how often each diabetes-related problem applied to them in the past month, on a six-point Likert scale (ranging from not a problem to serious problem), with scores reflecting a total across 14 items and higher scores indicating greater severity and a clinical cutoff of \>44. Scores can range from 14-84. |
| Five-Facet Mindfulness Questionnaire | Baseline, Immediate post-intervention follow up (2-3 months post baseline), 3 month follow up (5-6 months post-baseline) | Assessed via teen report. Scores are calculated as a total score across all items in the scale with a range of 1 (minimum) to 5 (maximum) and total scores presented are a sum of the sub scale (observing, describing, acting with awareness, nonjudging, and non-reactivity) with possible scores ranging from 5-25 with higher scores indicating more mindfulness. |
| PROMIS Depression Short Form - Adolescent Report | Baseline, Immediate post-intervention follow up (2-3 months post baseline), 3 month follow up (5-6 months post baseline) | Scores are calculated as t-scores with higher scores indicating more depressive symptoms. T-scores (range 0-100) over 55 indicate clinically significant depressive symptoms. Interpretation of t-scores is based on a mean of 50 and standard deviation of 10. |
| PROMIS Anxiety Short Form - Adolescent Report | Baseline, Immediate post-intervention (2-3 months post baseline), 3 month follow up (5-6 months post baseline) | Scores are calculated as t-scores (range 0-100) with higher scores indicating more anxiety symptoms.T-scores over 55 indicate clinically significant anxiety symptoms. Interpretation of t-scores is based on a mean of 50 and standard deviation of 10. |
| Diabetes Eating Problems Survey Revised | Baseline, Immediate post-intervention (2-3 months post baseline), 3 month follow up (5-6 months post baseline) | Teen report with higher scores indicating more disordered eating behaviors with scores over 25 indicating clinically significant problems. Total scores range from 0 to 64 with higher scores indicating more disordered eating behaviors. |
Countries
United States
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| BREATHE-T1D BREATHE-T1D is a 6-week group mindfulness program adapted specifically for teens with type 1 diabetes.
BREATHE-T1D: BREATHE-T1D is a mindfulness based intervention adapted from Learning to BREATHE specifically for teens with type 1 diabetes. | 20 |
| BREATHE-T1D Health Education The health education placebo comparator is a 6-week group diabetes-specific education program designed to be informational but not supportive.
BREATHE-T1D: BREATHE-T1D is a mindfulness based intervention adapted from Learning to BREATHE specifically for teens with type 1 diabetes. | 22 |
| Total | 42 |
Withdrawals & dropouts
| Period | Reason | FG000 | FG001 |
|---|---|---|---|
| Overall Study | Withdrawal by Subject | 2 | 1 |
Baseline characteristics
| Characteristic | BREATHE-T1D | Total | BREATHE-T1D Health Education |
|---|---|---|---|
| Age, Continuous | 14.9 years STANDARD_DEVIATION 1.8 | 14.8 years STANDARD_DEVIATION 1.8 | 14.7 years STANDARD_DEVIATION 1.9 |
| Anxiety | 58.8 T-score STANDARD_DEVIATION 7.9 | 57.6 T-score STANDARD_DEVIATION 7.6 | 57.1 T-score STANDARD_DEVIATION 7.2 |
| Depression | 58.5 T-score STANDARD_DEVIATION 9 | 56.7 T-score STANDARD_DEVIATION 8.6 | 56.2 T-score STANDARD_DEVIATION 8.7 |
| Diabetes Distress | 61.7 units on a scale STANDARD_DEVIATION 23.5 | 60.9 units on a scale STANDARD_DEVIATION 22.4 | 60.1 units on a scale STANDARD_DEVIATION 21.9 |
| Disordered Eating | 21.8 units on a scale STANDARD_DEVIATION 11.1 | 22.6 units on a scale STANDARD_DEVIATION 13.3 | 23.4 units on a scale STANDARD_DEVIATION 15.3 |
| Ethnicity (NIH/OMB) Hispanic or Latino | 1 Participants | 5 Participants | 4 Participants |
| Ethnicity (NIH/OMB) Not Hispanic or Latino | 19 Participants | 37 Participants | 18 Participants |
| Ethnicity (NIH/OMB) Unknown or Not Reported | 0 Participants | 0 Participants | 0 Participants |
| HbA1c | 7.7 percentage STANDARD_DEVIATION 1.1 | 8.2 percentage STANDARD_DEVIATION 2 | 8.7 percentage STANDARD_DEVIATION 2.5 |
| Race (NIH/OMB) American Indian or Alaska Native | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Asian | 0 Participants | 1 Participants | 1 Participants |
| Race (NIH/OMB) Black or African American | 5 Participants | 11 Participants | 6 Participants |
| Race (NIH/OMB) More than one race | 4 Participants | 10 Participants | 6 Participants |
| Race (NIH/OMB) Native Hawaiian or Other Pacific Islander | 1 Participants | 1 Participants | 0 Participants |
| Race (NIH/OMB) Unknown or Not Reported | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) White | 10 Participants | 19 Participants | 9 Participants |
| Region of Enrollment United States | 20 participants | 42 participants | 22 participants |
| Sex: Female, Male Female | 13 Participants | 28 Participants | 15 Participants |
| Sex: Female, Male Male | 7 Participants | 14 Participants | 7 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | 0 / 18 | 0 / 21 |
| other Total, other adverse events | 0 / 18 | 0 / 21 |
| serious Total, serious adverse events | 0 / 18 | 0 / 21 |
Outcome results
Number of Weeks to Enroll Participants to Form One Cohort
Number of weeks to enroll 10 participants to be randomized 5 per group
Time frame: During screening (10 months)
Population: All randomized participants
| Arm | Measure | Value (MEAN) |
|---|---|---|
| All Participants | Number of Weeks to Enroll Participants to Form One Cohort | 8 weeks |
Percentage of Attended Sessions
Number of intervention sessions (calculated by multiplying number of expected sessions by number of participants for total possible sessions held) attended divided by total number of intervention sessions expected per group.
Time frame: Immediate post-intervention follow-up (2-3 months post baseline)
Population: The aim was for each participant to attend 6 program sessions. Therefore, the number of expected sessions multiplied by the number of participants are reflected in the overall number of units analyzed.
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| All Participants | Percentage of Attended Sessions | 99 percentage of sessions attended overall |
| BREATHE-T1D Health Education | Percentage of Attended Sessions | 100 percentage of sessions attended overall |
Percentage of Enrolled of Eligible Participants Screened
The percentage is calculated first by identifying the number of enrolled participants divided by eligible participants. 42 total patients were eligible once screened across the 10 month enrollment period. 42 total then enrolled in the study.
Time frame: During screening (10 months total)
Population: Number of participants screened (42 in all across 10 months were eligible for the study following screening).
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| All Participants | Percentage of Enrolled of Eligible Participants Screened | 42 Participants |
Percentage of Participants With Data Collected
Number of participants with data at each time point.
Time frame: Baseline, Immediate post-intervention (2-3 months post baseline), 3 month follow up (5-6 months post baseline)
| Arm | Measure | Group | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| All Participants | Percentage of Participants With Data Collected | Immediate follow up | 18 Participants |
| All Participants | Percentage of Participants With Data Collected | 3 month follow up | 18 Participants |
| BREATHE-T1D Health Education | Percentage of Participants With Data Collected | 3 month follow up | 21 Participants |
| BREATHE-T1D Health Education | Percentage of Participants With Data Collected | Immediate follow up | 21 Participants |
Satisfaction With Intervention Program
Satisfaction report by participants
Time frame: Immediate post-intervention follow-up (2-3 months post-baseline)
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| All Participants | Satisfaction With Intervention Program | 15 Participants |
| BREATHE-T1D Health Education | Satisfaction With Intervention Program | 19 Participants |
Diabetes Eating Problems Survey Revised
Teen report with higher scores indicating more disordered eating behaviors with scores over 25 indicating clinically significant problems. Total scores range from 0 to 64 with higher scores indicating more disordered eating behaviors.
Time frame: Baseline, Immediate post-intervention (2-3 months post baseline), 3 month follow up (5-6 months post baseline)
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| All Participants | Diabetes Eating Problems Survey Revised | Immediate follow up | 18.6 score on a scale | Standard Deviation 13.1 |
| All Participants | Diabetes Eating Problems Survey Revised | 3 month follow up | 19.3 score on a scale | Standard Deviation 13.1 |
| BREATHE-T1D Health Education | Diabetes Eating Problems Survey Revised | Immediate follow up | 18.2 score on a scale | Standard Deviation 14.2 |
| BREATHE-T1D Health Education | Diabetes Eating Problems Survey Revised | 3 month follow up | 20.0 score on a scale | Standard Deviation 16.5 |
Five-Facet Mindfulness Questionnaire
Assessed via teen report. Scores are calculated as a total score across all items in the scale with a range of 1 (minimum) to 5 (maximum) and total scores presented are a sum of the sub scale (observing, describing, acting with awareness, nonjudging, and non-reactivity) with possible scores ranging from 5-25 with higher scores indicating more mindfulness.
Time frame: Baseline, Immediate post-intervention follow up (2-3 months post baseline), 3 month follow up (5-6 months post-baseline)
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| All Participants | Five-Facet Mindfulness Questionnaire | Immediate follow up | 19.4 score on a scale | Standard Deviation 2.2 |
| All Participants | Five-Facet Mindfulness Questionnaire | 3 month follow up | 19.9 score on a scale | Standard Deviation 2.9 |
| BREATHE-T1D Health Education | Five-Facet Mindfulness Questionnaire | Immediate follow up | 18.5 score on a scale | Standard Deviation 3.3 |
| BREATHE-T1D Health Education | Five-Facet Mindfulness Questionnaire | 3 month follow up | 19.1 score on a scale | Standard Deviation 3.7 |
Glycemic Control
HbA1c is a measure of an average blood glucose level over the past 3 months and will be abstracted from the medical record as it is assessed at each regular diabetes clinic visit. HbA1c typically ranges from 4% to \>14%.
Time frame: Baseline, immediate post intervention follow up (2-3 months post baseline), 3 month follow up (5-6 months post baseline)
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| All Participants | Glycemic Control | Immediate follow up | 7.95 percentage | Standard Deviation 1.3 |
| All Participants | Glycemic Control | 3 month follow up | 7.6 percentage | Standard Deviation 1 |
| BREATHE-T1D Health Education | Glycemic Control | Immediate follow up | 8.79 percentage | Standard Deviation 2.5 |
| BREATHE-T1D Health Education | Glycemic Control | 3 month follow up | 8.7 percentage | Standard Deviation 2.6 |
Interventionist Adherence to Session Manuals
Supervisors listened to recordings of sessions for both programs and completed checklists assessing for the number of expected intervention components included in the sessions. Therefore, values reflect the percentage of expected intervention components included across all program sessions calculated at the end of the intervention period (week 6) for each group cohort.
Time frame: Week 6 of intervention
Population: All participants were included as these were ratings of sessions, not individual by participant.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| All Participants | Interventionist Adherence to Session Manuals | 100 percentage of intervention components | Standard Deviation 0 |
| BREATHE-T1D Health Education | Interventionist Adherence to Session Manuals | 100 percentage of intervention components | Standard Deviation 0 |
Mindful Attention Awareness Scale
Assessed via teen report. Scores are calculated as an average score of all items with a range of 1 (minimum) to 6 (maximum) with higher scores indicating more mindful attention in daily life.
Time frame: Baseline, Immediate post-intervention (2-3 months post baseline), 3 month follow up (5-6 months post baseline)
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| All Participants | Mindful Attention Awareness Scale | Immediate follow up | 3.8 score on a scale | Standard Deviation 0.87 |
| All Participants | Mindful Attention Awareness Scale | 3 month follow up | 3.9 score on a scale | Standard Deviation 1.3 |
| BREATHE-T1D Health Education | Mindful Attention Awareness Scale | Immediate follow up | 3.8 score on a scale | Standard Deviation 0.99 |
| BREATHE-T1D Health Education | Mindful Attention Awareness Scale | 3 month follow up | 3.9 score on a scale | Standard Deviation 1 |
Problem Areas in Diabetes - Teen
The Problem Areas in Diabetes-Teen (PAID-T) is a 14-item measure of diabetes distress in adolescents with type 1 diabetes. Adolescents are asked how often each diabetes-related problem applied to them in the past month, on a six-point Likert scale (ranging from not a problem to serious problem), with scores reflecting a total across 14 items and higher scores indicating greater severity and a clinical cutoff of \>44. Scores can range from 14-84.
Time frame: Baseline, immediate post intervention (2-3 months post baseline), 3 month follow up (5-6 months post baseline)
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| All Participants | Problem Areas in Diabetes - Teen | Immediate follow up | 49.8 score on a scale | Standard Deviation 22.4 |
| All Participants | Problem Areas in Diabetes - Teen | 3 month follow up | 46.8 score on a scale | Standard Deviation 19.4 |
| BREATHE-T1D Health Education | Problem Areas in Diabetes - Teen | Immediate follow up | 53.1 score on a scale | Standard Deviation 22.7 |
| BREATHE-T1D Health Education | Problem Areas in Diabetes - Teen | 3 month follow up | 49.1 score on a scale | Standard Deviation 21.1 |
PROMIS Anxiety Short Form - Adolescent Report
Scores are calculated as t-scores (range 0-100) with higher scores indicating more anxiety symptoms.T-scores over 55 indicate clinically significant anxiety symptoms. Interpretation of t-scores is based on a mean of 50 and standard deviation of 10.
Time frame: Baseline, Immediate post-intervention (2-3 months post baseline), 3 month follow up (5-6 months post baseline)
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| All Participants | PROMIS Anxiety Short Form - Adolescent Report | Immediate follow up | 56.7 T-score | Standard Deviation 6.6 |
| All Participants | PROMIS Anxiety Short Form - Adolescent Report | 3 month follow up | 53.8 T-score | Standard Deviation 7.6 |
| BREATHE-T1D Health Education | PROMIS Anxiety Short Form - Adolescent Report | Immediate follow up | 53.8 T-score | Standard Deviation 8.1 |
| BREATHE-T1D Health Education | PROMIS Anxiety Short Form - Adolescent Report | 3 month follow up | 54.0 T-score | Standard Deviation 8.6 |
PROMIS Depression Short Form - Adolescent Report
Scores are calculated as t-scores with higher scores indicating more depressive symptoms. T-scores (range 0-100) over 55 indicate clinically significant depressive symptoms. Interpretation of t-scores is based on a mean of 50 and standard deviation of 10.
Time frame: Baseline, Immediate post-intervention follow up (2-3 months post baseline), 3 month follow up (5-6 months post baseline)
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| All Participants | PROMIS Depression Short Form - Adolescent Report | Immediate follow up | 55.9 t-score | Standard Deviation 9.4 |
| All Participants | PROMIS Depression Short Form - Adolescent Report | 3 month follow up | 53.0 t-score | Standard Deviation 9.6 |
| BREATHE-T1D Health Education | PROMIS Depression Short Form - Adolescent Report | Immediate follow up | 54.8 t-score | Standard Deviation 9.8 |
| BREATHE-T1D Health Education | PROMIS Depression Short Form - Adolescent Report | 3 month follow up | 56.0 t-score | Standard Deviation 9.2 |
Self-Care Inventory
Teen report on the Self-Care Inventory, a measure of diabetes management with higher scores indicating better self-care for diabetes. Average scores range from 1 (minimum) to 5 (maximum).
Time frame: Baseline, Immediate post-intervention (2-3 months post baseline), 3 month follow up (5-6 months post baseline)
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| All Participants | Self-Care Inventory | Immediate follow up | 3.73 units on a scale | Standard Deviation 0.66 |
| All Participants | Self-Care Inventory | 3 month follow up | 3.68 units on a scale | Standard Deviation 0.71 |
| BREATHE-T1D Health Education | Self-Care Inventory | Immediate follow up | 3.53 units on a scale | Standard Deviation 0.77 |
| BREATHE-T1D Health Education | Self-Care Inventory | 3 month follow up | 3.48 units on a scale | Standard Deviation 0.76 |
UPPS-P Negative Urgency Subscale
Teen report on the UPPS-P Negative Urgency subscale with higher scores indicating more likelihood to act impulsively when experiencing a negative mood. Scores are calculated with an average which can range from 1(minimum) to 4 (maximum).
Time frame: Baseline, Immediate post-intervention (2-3 months post baseline), 3 month follow up (5-6 months post baseline)
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| All Participants | UPPS-P Negative Urgency Subscale | 3 month follow up | 2.65 score on a scale | Standard Deviation 0.58 |
| All Participants | UPPS-P Negative Urgency Subscale | Immediate follow up | 2.52 score on a scale | Standard Deviation 0.85 |
| BREATHE-T1D Health Education | UPPS-P Negative Urgency Subscale | Immediate follow up | 2.42 score on a scale | Standard Deviation 0.68 |
| BREATHE-T1D Health Education | UPPS-P Negative Urgency Subscale | 3 month follow up | 2.64 score on a scale | Standard Deviation 0.63 |